A Non-oncogenic HPV 16 E6/E7 Vaccine Enhances Treatment of HPV Expressing Tumors

A Non-oncogenic HPV 16 E6/E7 Vaccine Enhances Treatment of HPV Expressing Tumors

Human papillomaviruses (HPVs) are the causative factor for greater than 90% of cervical cancers and 25% of head and neck cancers. The incidence of HPV positive (+) head and neck squamous cell carcinomas (HNSCCs) has greatly increased in the last 30 years. E6 and E7 are the two key viral oncoproteins...

Full description

Bibliographic Details
Main Authors: Wieking, Bryant G., Vermeer, Daniel W., Spanos, William C., Lee, Kimberly M., Vermeer, Paola, Lee, Walter T., Xu, Younong, Gabitzsch, Elizabeth S., Balcaitis, Stephanie, Balint, Joseph P., Jones, Frank R., Lee, John H.
Format: Online
Language:English
Published: 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571619/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571619/

Similar Items